223 related articles for article (PubMed ID: 2743082)
1. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade.
Jones RL; Wilson NH; Lawrence RA
Br J Pharmacol; 1989 Apr; 96(4):875-87. PubMed ID: 2743082
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
Tymkewycz PM; Jones RL; Wilson NH; Marr CG
Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
[TBL] [Abstract][Full Text] [Related]
3. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitory prostanoid receptor in piglet saphenous vein.
Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
[TBL] [Abstract][Full Text] [Related]
5. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
Lumley P; White BP; Humphrey PP
Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Lydford SJ; McKechnie K
Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
[TBL] [Abstract][Full Text] [Related]
9. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
10. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.
Jones RL; Peesapati V; Wilson NH
Br J Pharmacol; 1982 Jul; 76(3):423-38. PubMed ID: 6286023
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
13. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets.
Halushka PV; Mais DE; Garvin M
Eur J Pharmacol; 1986 Nov; 131(1):49-54. PubMed ID: 3816947
[TBL] [Abstract][Full Text] [Related]
14. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
Krauss AH; Woodward DF; Chen J; Gibson LL; Lai RK; Protzman CE; Shan T; Williams LS; Gac TS; Burk RM
J Ocul Pharmacol Ther; 1995; 11(3):203-12. PubMed ID: 8590251
[TBL] [Abstract][Full Text] [Related]
15. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145.
Arimura A; Miwa M; Hasegawa H; Kishino J; Notoya M; Yasui K; Komori M; Iwata S
Br J Pharmacol; 1998 Jun; 124(4):795-803. PubMed ID: 9690873
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea.
Coleman RA; Kennedy I
Prostaglandins; 1985 Mar; 29(3):363-75. PubMed ID: 2988018
[TBL] [Abstract][Full Text] [Related]
17. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
18. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
Narumiya S; Okuma M; Ushikubi F
Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
[TBL] [Abstract][Full Text] [Related]
19. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
[TBL] [Abstract][Full Text] [Related]
20. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
